GAINESVILLE, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- X-tosis, Inc., a pre-clinical biotech company transforming the treatment ...

MYOS Corp., a leader in proactive muscle health supplements, encourages partnering with your pet to achieve shared longevity ...

Primo Biotechnology (“Primo”) today announced a strategic partnership with SHINE Technologies, LLC, (“SHINE”) a global leader ...

For those who prefer a discreet way to consume THC, Black Tie CBD’s THC gummies are the perfect choice. Each gummy is infused ...

“The new KL1v represents more than just an update – it’s a testament to Capsa Healthcare’s unwavering commitment to innovation and excellence in pharmacy automation,” said Huan K. Nguyen, R.Ph., VP of ...

AdhereTech, Inc., the market-leading provider of real-time medication adherence solutions proven to help patients remain compliant with clinical study protocols and adherent with prescribed dosing ...

As Part of the Settlement, Teva Receives a License to Market Generic FIRDAPSE Beginning in February 2035. CORAL GABLES, Fla., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceut ...

I welcome the opportunity of sharing novel information about our company and the secreted form of the Klotho anti-aging gene, ’s-KL’, the patent protected development platform on which our product ...

BALTIMORE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals, a pioneer in non-degrading molecular glue therapeutics, announced today that it will host an executive roundtable at the WuXi ...

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, has delivered its first Vega systems to Berry Genomics as part of an early access agreement announced in 2022.

Kingswood Capital Partners, LLC ("Kingswood") acted as the sole book-running manager for the Offering. Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to the Company, and VCL Law LLP ...

SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, President and CEO, and Sam ...